May 5, 2026 Sophia Vida
Breaking News

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

Expands use of Nociscan in groundbreaking trial with Roger Härtl, MD Broomfield, CO, May 05, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) –  Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan® platform to help physicians … Continue reading “Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine”